ADPT: Adaptive Biotech Kompaniya qiymatining sof foydaga nisbati
Adaptive Biotechnologies daromadlari diagnostika tizimlari savdosi va sog'liqni saqlash gigantlari bilan hamkorlikka asoslangan. Kompaniyaning foydaga nisbatan narx koeffitsiyenti bozor ishonchining ko'rsatkichi bo'lib xizmat qiladi, bunda -70.10 qiymati aktivning joriy baholash darajasini tavsiflaydi. O'sish ko'p milliard dollarlik shartnomalar orqali clonoSEQ texnologiyasining kengayishi bilan ta'minlanmoqda, genom tahlili esa tashqi bulutli xizmatlar bilan moslashuvchan integratsiyaga tayanadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_ADPT_-_Adaptive-Biotechnologies_-_PE-Multiple "ADPT: Adaptive Biotechnologies Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Adaptive Biotechnologies Corp (ADPT) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Adaptive Biotechnologies|ADPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Adaptive Biotechnologies Inc.|ADPT - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Adaptive Biotechnologies Corporation|ADPT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Adaptive Biotechnologies|Tezkor likvidlik koeffitsiyenti adaptivebiotech.com
- foyda va bozor multiplikatorlari tafsilotlari:
ADPT - Sof foyda|Sof foyda prognozi Adaptive Biotechnologies|ADPT - P/E multiplikatori|Forvard P/E multiplikatori Adaptive Biotech|ADPT - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Adaptive Biotechnologies Corporation|ADPT - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Adaptive Biotechnologies|ADPT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi adaptivebiotech.com|ADPT - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Adaptive Biotechnologies
Kompaniyaning har tomonlama tahlili:adaptivebiotech.com ADPT
P/E koeffitsiyenti bozor narxi va yillik daromadlar o'rtasidagi bog'liqlik orqali biznes qiymatini aks ettiradi va pul oqimini yaratish samaradorligini baholash imkonini beradi. Adaptive Biotechnologies (ADPT) kompaniyasining FDA qarorlariga bog'liqligi va mijozlar bazasining sekin kengayishini hisobga olgan holda, kompaniyaning konsolidatsiyalashgan P/E koeffitsiyenti aktivlarning vaqtincha past baholanishini tizimli model inqirozidan ajratishga yordam beradi va "qiymat tuzog'iga" investitsiya kiritish xavfini bartaraf etadi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics Inc|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|PGEN - P/E multiplikatori|PHAR: P/E multiplikatori|Narx-foyda multiplikatori NKTR|UPB (Upstream Bio) - P/E multiplikatori|P/E multiplikatori Zenas Bio|Narxning foydaga nisbati Immunome Corp (IMNM)|GOSS: Kapitalizatsiyaning sof foydaga nisbati|KalVista Pharmaceuticals - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati SEPN (septerna.com)|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati Savara Inc SVRA|RIGL (Rigel Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|ANAB (AnaptysBio Inc.) - Narxning foydaga nisbati|ATXS (Astria Therapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati engene.com ENGN|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|JBIO (aerovatetx.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris)|Kyverna Therapeutics, Inc - Narxning foydaga nisbati|Tiziana Life Sciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati cabalettabio.com CABA|Ventyx Biosciences, Inc. (VTYX) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Theratechnologies, Inc. (THTX)|Narx-foyda koeffitsiyenti AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Bozor narxining sof foydaga nisbati|P/E multiplikatori AGEN|CLYM - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|ATYR - Narx-foyda koeffitsiyenti|Adagene Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati IMA (ImageneBio Inc)|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda multiplikatori EQ|Narxning foydaga nisbati Connect Biopharma Holdings|Kapitalizatsiyaning foydaga nisbati Immunic Inc IMUX|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|Narxning foydaga nisbati IFRX (inflarx.de)|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|Adicet Bio Inc. (ACET) - Kapitalizatsiyaning foydaga nisbati|Celularity Corp - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti INmune Bio Inc (INMB)|BRNS: P/E multiplikatori|KZR - Biznesning o‘zini qoplash muddati|SABS (SAB Biotherapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati akaritx.com AKTX|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Biznesning o‘zini qoplash muddati q32bio.com|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|iBio, Inc. - P/E multiplikatori|CARM (Carisma Therapeutics) - Narx-foyda multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati BOLT (Bolt Biotherapeutics, Inc.)|Narx-foyda koeffitsiyenti HCWB|APVO (Aptevo) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|ADTX: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Kompaniya qiymatining sof foydaga nisbati XRTX|ReShape Lifesciences - P/E multiplikatori|REVB - P/E multiplikatori|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|scinai.com - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|P/E multiplikatori ALLK|P/E multiplikatori hookipapharma.com (HOOK)|IGM Biosciences - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ITOS|Ocean Biomedical - P/E multiplikatori|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
